384 related articles for article (PubMed ID: 20728965)
1. Synthesis of new pyrazole derivatives and their anticancer evaluation.
Nitulescu GM; Draghici C; Missir AV
Eur J Med Chem; 2010 Nov; 45(11):4914-9. PubMed ID: 20728965
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 1-benzyl-3-(5-hydroxymethyl-2-furyl)selenolo[3,2-c]pyrazole derivatives as new anticancer agents.
Chou LC; Huang LJ; Hsu MH; Fang MC; Yang JS; Zhuang SH; Lin HY; Lee FY; Teng CM; Kuo SC
Eur J Med Chem; 2010 Apr; 45(4):1395-402. PubMed ID: 20097456
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
[TBL] [Abstract][Full Text] [Related]
5. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity.
El-Deeb IM; Lee SH
Bioorg Med Chem; 2010 Jun; 18(11):3961-73. PubMed ID: 20472440
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents.
Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN
Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928
[TBL] [Abstract][Full Text] [Related]
9. New pyrazolic compounds as cytotoxic agents.
Bouabdallah I; M'Barek LA; Zyad A; Ramdani A; Zidane I; Melhaoui A
Nat Prod Res; 2007 Apr; 21(4):298-302. PubMed ID: 17479417
[TBL] [Abstract][Full Text] [Related]
10. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents.
Rostom SA
Bioorg Med Chem; 2010 Apr; 18(7):2767-76. PubMed ID: 20207545
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
Poreba K; Wietrzyk J; Opolski A
Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives.
Congiu C; Onnis V; Vesci L; Castorina M; Pisano C
Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096
[TBL] [Abstract][Full Text] [Related]
13. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
Al-Saadi MS; Rostom SA; Faidallah HM
Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
[TBL] [Abstract][Full Text] [Related]
15. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-3H-pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones. Design, synthesis, and biological activity of new antitumor agents.
Almerico AM; Mingoia F; Diana P; Barraja P; Lauria A; Montalbano A; Cirrincione G; Dattolo G
J Med Chem; 2005 Apr; 48(8):2859-66. PubMed ID: 15828824
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents.
Kock I; Heber D; Weide M; Wolschendorf U; Clement B
J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and bioactivities of novel pyrazole and triazole derivatives containing 5-phenyl-2-furan.
Cui ZN; Shi YX; Cui JR; Ling Y; Li BJ; Yang XL
Chem Biol Drug Des; 2012 Jan; 79(1):121-7. PubMed ID: 22023821
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, spectroscopy (IR, multinuclear NMR, ESI-MS), diffraction, density functional study and in vitro antiproliferative activity of pyrazole-beta-diketone dihalotin(IV) compounds on 5 melanoma cell lines.
Pettinari C; Caruso F; Zaffaroni N; Villa R; Marchetti F; Pettinari R; Phillips C; Tanski J; Rossi M
J Inorg Biochem; 2006 Jan; 100(1):58-69. PubMed ID: 16313961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
